风湿性疾病与肺部健康之间的相互作用
Yuliya Fedorchenko1, Olena Zimba2,3,4, Roman Yatsyshyn5
1Department of Pathophysiology, Ivano-Frankivsk National Medical University, Halytska Str. 2, Ivano-Frankivsk, 76018, Ukraine. juliakozubash@gmail.com.
Rheumatology international
|March 21, 2024
概括
风湿性疾病经常导致间歇性肺病 (ILD),特别是在全身性硬化和炎症性肌肉病. 早期诊断和协作护理对于管理风湿性关节炎相关的ILD肺部并发症至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 风湿性疾病 (RDs) 经常导致由于炎症和自身免疫过程导致的呼吸道并发症.
- 间歇性肺病 (ILD) 是类风湿性关节炎 (RA),全身性硬化症 (SSc) 和炎症性异常性肌病 (IIM) 的常见和渐进性并发症.
- 在RD中ILD的患病率:11%在RA中,47%在SSc中,41%在IIM中.
研究的目的:
- 要突出类风湿性疾病和间歇性肺部疾病之间的显著联系.
- 讨论RDS中的诊断标记和肺纤维化进展性质.
- 重新评估治疗策略,包括疾病修饰性抗风湿药物 (DMARDs),用于管理RDs中的肺参与.
主要方法:
- 对有关风湿性疾病和相关间歇性肺病的当前文献的综述.
- 对肺部参与的诊断标志物 (KL-6,TNF-α,IL-6,抗CCP) 的分析.
- 对治疗方法的评估,包括在RA-ILD中DMARDs (如甲醇) 的作用.
主要成果:
- 在RD中,ILD是一种普遍的并发症,不同类型的类风湿病的发病率各不相同.
- 特定的生物标志物有助于评估和预测RDS肺病的进展.
- 尽管有先前的担忧,但甲托雷克萨特在治疗RA相关的ILD方面显示出潜在的益处.
结论:
- 了解自身免疫性RD和肺部疾病之间的联系对于有效的管理至关重要.
- 风湿病学家和肺病学家之间的协作护理对于早期诊断和RA-ILD的最佳结果至关重要.
- 对DMARDs对RDs肺病进展的影响进行进一步研究是有必要的.
相关概念视频
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
COPD: Pathogenesis and Clinical Features
271
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
271


